{"entity":{"id":"sinocelltech","kind":"company","name":"Sinocelltech","aka":["Sinocelltech Ltd."],"tldr":"Sinocelltech is a China-based biotechnology company running 8 late-stage cancer trials of SCTB41, SCTB35 and SCTC21C in multiple myeloma, non-small-cell lung cancer and diffuse large B-cell lymphoma.","summary":"Sinocelltech, based in Beijing, China, is a biotechnology company. Sinocelltech is a biopharmaceutical company that researches, manufactures and commercialises monoclonal antibodies, recombinant proteins and vaccines. On ClinicalTrials.gov it is the lead sponsor of 8 recruiting or active phase 2 and phase 3 interventional cancer trials (6 in phase 3), testing SCTB41, SCTB35, SCTC21C, SCTB39-1 and SCTB14 in multiple myeloma, non-small-cell lung cancer, diffuse large B-cell lymphoma and follicular lymphoma. The largest, NCT06041061 (A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years), plans to enrol 18000 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.sinocelltech.com"},{"label":"ClinicalTrials.gov: trials led by Sinocelltech","url":"https://clinicaltrials.gov/search?lead=Sinocelltech%20Ltd."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["multiple-myeloma","nsclc","dlbcl","follicular-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["sctb41","sctb35","sctc21c","sctb14"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06600022","nct06041061","nct07050641"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Beijing","country":"CN","companyType":"biotech","website":"https://www.sinocelltech.com","founded":2002,"stage":"public","investors":[],"funding":[]},"route":"/companies/sinocelltech/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"follicular-lymphoma","kind":"cancer","name":"Follicular lymphoma","route":"/cancers/follicular-lymphoma/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"sctb14","kind":"drug","name":"SCTB14","route":"/drugs/sctb14/"},{"id":"sctb35","kind":"drug","name":"SCTB35","route":"/drugs/sctb35/"},{"id":"sctb41","kind":"drug","name":"SCTB41","route":"/drugs/sctb41/"},{"id":"sctc21c","kind":"drug","name":"SCTC21C","route":"/drugs/sctc21c/"}],"trial":[{"id":"nct07609251","kind":"trial","name":"A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study","route":"/trials/nct07609251/"},{"id":"nct06041061","kind":"trial","name":"A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years","route":"/trials/nct06041061/"},{"id":"nct07570823","kind":"trial","name":"A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","route":"/trials/nct07570823/"},{"id":"nct07562022","kind":"trial","name":"A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma","route":"/trials/nct07562022/"},{"id":"nct07297329","kind":"trial","name":"A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","route":"/trials/nct07297329/"},{"id":"nct07362459","kind":"trial","name":"A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer","route":"/trials/nct07362459/"},{"id":"nct06600022","kind":"trial","name":"Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.","route":"/trials/nct06600022/"},{"id":"nct07050641","kind":"trial","name":"Phase I/II Study of SCTB39-1 in Advanced Solid Tumours","route":"/trials/nct07050641/"},{"id":"nct07662395","kind":"trial","name":"SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer","route":"/trials/nct07662395/"}]}}